The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-5,5-dimethyl-7-(1-phenylethyl)-2-(pyridin-3-ylamino)-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one ID: ALA3884884
PubChem CID: 70942743
Max Phase: Preclinical
Molecular Formula: C21H21N5O
Molecular Weight: 359.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C[C@@H](c1ccccc1)N1C(=O)C(C)(C)c2cnc(Nc3cccnc3)nc21
Standard InChI: InChI=1S/C21H21N5O/c1-14(15-8-5-4-6-9-15)26-18-17(21(2,3)19(26)27)13-23-20(25-18)24-16-10-7-11-22-12-16/h4-14H,1-3H3,(H,23,24,25)/t14-/m0/s1
Standard InChI Key: LNCUDNJUDSTTIM-AWEZNQCLSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
1.1061 -9.8517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5188 -9.1459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7013 -9.1414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1271 -10.5144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8351 -10.9233 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5448 -10.5139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5420 -9.6912 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1282 -9.6948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8355 -9.2852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6644 -8.4859 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8514 -8.4016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2116 -7.8775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0117 -8.0484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4428 -7.6939 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2531 -10.9214 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9602 -10.5117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6652 -10.9196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3718 -10.5106 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3710 -9.6925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6576 -9.2852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9540 -9.6965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9592 -7.1002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2613 -8.8283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0606 -8.9994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6096 -8.3916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3537 -7.6101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5550 -7.4427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
8 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 9 2 0
8 9 1 0
9 10 1 0
10 11 1 0
11 2 1 0
2 8 1 0
12 13 1 0
10 12 1 0
11 14 2 0
6 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
12 22 1 1
13 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 13 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 359.43Molecular Weight (Monoisotopic): 359.1746AlogP: 4.00#Rotatable Bonds: 4Polar Surface Area: 71.01Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.43CX Basic pKa: 5.27CX LogP: 3.75CX LogD: 3.75Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.76Np Likeness Score: -1.02
References 1. Katz JD, Haidle A, Childers KK, Zabierek AA, Jewell JP, Hou Y, Altman MD, Szewczak A, Chen D, Harsch A, Hayashi M, Warren L, Hutton M, Nuthall H, Su HP, Munshi S, Stanton MG, Davies IW, Munoz B, Northrup A.. (2017) Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitors., 27 (1): [PMID:27816515 ] [10.1016/j.bmcl.2016.08.068 ]